# A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics

> **NCT00240370** · PHASE3 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 1159 (—)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Muraglitazar

## Key facts

- **NCT ID:** NCT00240370
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2005-03
- **Final completion:** —
- **Target enrollment:** 1159 (—)
- **Last updated:** 2010-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00240370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00240370, "A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00240370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*